XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144 $ 38,560,117 $ (45,222,302) $ 16,143,619
Balance (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278      
Provision for compensation expense related to stock-based compensation 305,229 305,229
Exercise of stock options into common stock $ 17 137,040 137,057
Exercise of stock options into common stock (in Shares)     162,956      
Net loss (2,380,935) (2,380,935)
Balance at Mar. 31, 2022 $ 851,660 $ 21,952,000 $ 2,161 39,002,386 (47,603,237) 14,204,970
Balance (in Shares) at Mar. 31, 2022 170,332 21,952 21,605,234      
Balance at Dec. 31, 2022 $ 851,660 $ 21,952,000 $ 2,176 39,819,420 (31,590,583) 31,034,673
Balance (in Shares) at Dec. 31, 2022 170,332 21,952 21,750,804      
Provision for compensation expense related to stock-based compensation 420,748 420,748
Exercise of stock options into common stock 1,185 1,185
Exercise of stock options into common stock (in Shares)     1,500      
Net loss (230,215) (230,215)
Balance at Mar. 31, 2023 $ 851,660 $ 21,952,000 $ 2,176 $ 40,241,353 $ (31,820,798) $ 31,226,391
Balance (in Shares) at Mar. 31, 2023 170,332 21,952 21,752,304